| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 26, 2024 | HAE Haemonetics Corp | Strong Stewart W67 | President, Global Hospital | Sell | 4,312 | $91.15 | $393,038.80 | -19.2% | -16.7% | -17.4% | |
| Jul 26, 2024 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 3,000 | $4.75 | $14,238.00 | -2.1% | -20.7% | -53.0% | |
| Jul 25, 2024 | INCY Incyte Corp | Iyengar Vijay K62 | EVP, Gmapps | Sell | 15,571 | $70.00 | $1,089,970.00 | -29.8% | -5.0% | +2.4% | |
| Jul 24, 2024 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 723 | $4.02 | $2,906.46 | -0.3% | -85.3% | -69.4% | |
| Jul 23, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 8,788 | $1.09 | $9,578.92 | - | -31.3% | -37.6% | |
| Jul 23, 2024 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 2,818 | $458.13 | $1,291,010.34 | -90.4% | +14.0% | +10.3% | |
| Jul 23, 2024 | ISRG Intuitive Surgical Inc | Barratt Craig H48 | Director | Sell | 1,400 | $458.13 | $641,382.00 | -100% | +14.0% | +10.3% | |
| Jul 18, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 100 | $7.96 | $795.90 | -0.2% | +4.9% | +32.3% | |
| Jul 18, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 80 | $7.96 | $636.59 | -0.2% | +4.9% | +32.3% | |
| Jul 18, 2024 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 24,162 | $1.90 | $45,907.80 | -1.8% | -51.8% | +92.6% | |
| Jul 18, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 27 | $7.97 | $215.09 | -0.2% | +4.9% | +32.3% | |
| Jul 18, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 12,710 | $1.13 | $14,352.30 | - | -30.2% | -41.6% | |
| Jul 17, 2024 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 15,000 | $202.52 | $3,037,744.00 | -0.4% | +1.7% | +13.2% | |
| Jul 17, 2024 | HOLX Hologic Inc | Stamoulis Christiana | Director | Sell | 9,039 | $79.50 | $718,600.50 | -16.6% | +3.5% | -18.8% | |
| Jul 17, 2024 | HOLX Hologic Inc | MacMillan Stephen P54 | Chairman, President And CEO | Sell | 3,672 | $80.13 | $294,222.67 | -0.3% | +3.5% | -18.8% | |
| Jul 17, 2024 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 23,762 | $1.94 | $46,086.64 | -0.9% | -55.5% | +91.5% | |
| Jul 16, 2024 | LMAT Lemaitre Vascular Inc | Lemaitre George W54 | Chairman And CEO | Sell | 57,372 | $86.69 | $4,973,790.96 | -2.9% | +5.9% | -5.1% | |
| Jul 16, 2024 | INCY Incyte Corp | Flannelly Barry P50 | EVP &General Manager Us | Sell | 1,306 | $64.19 | $83,832.14 | -2.2% | +2.2% | +8.2% | |
| Jul 15, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 91 | $1.14 | $103.74 | - | -35.1% | -42.7% | |
| Jul 15, 2024 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 8,625 | $145.17 | $1,252,050.99 | -2.6% | -7.0% | -19.9% | |
| Jul 15, 2024 | SSKN Strata Skin Sciences, Inc. | Accelmed Partners, L.P. | 10% Owner | Buy | 230,573 | $3.14 | $723,999.22 | +19.0% | -6.4% | -24.8% | |
| Jul 15, 2024 | SSKN Strata Skin Sciences, Inc. | Geiger Uri | Director, 10% Owner | Buy | 230,573 | $3.14 | $723,999.22 | +19.0% | -6.4% | -24.8% | |
| Jul 15, 2024 | SSKN Strata Skin Sciences, Inc. | Rafaeli Dolev | Chief Executive Officer | Buy | 19,100 | $3.14 | $59,974.00 | +15.4% | -6.4% | -24.8% | |
| Jul 15, 2024 | LMAT Lemaitre Vascular Inc | Lemaitre George W54 | Chairman And CEO | Sell | 40,006 | $86.21 | $3,448,752.15 | -1.0% | +6.8% | -4.7% | |
| Jul 12, 2024 | HAE Haemonetics Corp | Lingamneni Anila62 | EVP, Chief Technology Officer | Sell | 2,215 | $90.00 | $199,350.00 | -4.9% | -17.8% | -16.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.